Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy

BACKGROUND: Assessing serological inflammation is difficult in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients, as standard inflammation parameters, like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are influenced by interleukin-6-receptor inhibition. Calprotectin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gernert, Michael, Schmalzing, Marc, Tony, Hans-Peter, Strunz, Patrick-Pascal, Schwaneck, Eva Christina, Fröhlich, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389811/
https://www.ncbi.nlm.nih.gov/pubmed/35986420
http://dx.doi.org/10.1186/s13075-022-02887-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389811/
https://www.ncbi.nlm.nih.gov/pubmed/35986420
http://dx.doi.org/10.1186/s13075-022-02887-7

Ejemplares similares